May 02, 2025
Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation
Apr 09, 2025
Seegene Announces Development of CURECA(TM), a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation
Mar 20, 2025
Seegene Unveils HPV Genotyping Solution at EUROGIN 2025
Oct 24, 2024
Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative
Oct 08, 2024
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative
Sep 02, 2024
Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays
Aug 26, 2024
Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration
Aug 05, 2024
Seegene Showcased its Multiplex Technology at ADLM 2024
Jul 16, 2024
Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024
May 16, 2024
Seegene and Springer Nature Announce Strategic Alliance
Apr 08, 2024
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"
Jan 24, 2024
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'
Feb 15, 2021
Seegene's saliva test for COVID-19 is just as effective as NPS test
Jan 31, 2021
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants
Jan 20, 2021
Seegene to advance business in Latin America in the New Year
Jan 06, 2021
Seegene's COVID-19 test with saliva sample collection feature now available in Europe
Dec 03, 2020
Seegene's COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe
May 18, 2020
Seegene Exports 10 million Corona Tests to Brazil
Apr 21, 2020
Seegene's Allplex(TM) 2019-nCoV Assay receives FDA Emergency Use Authorization
Apr 20, 2020
Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries